Categories : Endocrine & Metabolic
Product Packaging : 10x10 Blister
Product Composition : 10 mg + 5 mg / 25 mg + 5 mg
Send MessageEmpagliflozin + Linagliptin Tablets are combination antidiabetic medicines used for the management of Type 2 Diabetes Mellitus in adults. The formulation combines the SGLT2 inhibitor activity of Empagliflozin with the DPP-4 inhibitor action of Linagliptin, helping improve glycemic control through complementary mechanisms. Genliva Wellness LLP is a trusted Empagliflozin + Linagliptin Tablet Manufacturer in India offering high-quality diabetic care formulations.
The medicine is commonly prescribed when blood glucose levels are not adequately controlled with diet, exercise, or single-drug therapy. Genliva Wellness LLP is also a reliable Empagliflozin + Linagliptin Tablet Exporter from India supplying quality pharmaceutical products to international healthcare markets.
This combination is widely utilized in modern diabetes management protocols due to its ability to improve blood sugar control while supporting overall metabolic health. The product forms part of our specialized range of Type 2 Diabetes Management Medicines.
Empagliflozin + Linagliptin Tablets are formulated to provide dual-action blood glucose management.
Empagliflozin + Linagliptin Tablets are used in the treatment and management of diabetes-related conditions.
Empagliflozin + Linagliptin Tablets provide complementary glucose-lowering effects for improved diabetes management.
